Pulmonx Corp. (LUNG)
1.99
-0.09
(-4.33%)
USD |
NASDAQ |
Sep 09, 16:00
1.99
0.00 (0.00%)
After-Hours: 17:07
Pulmonx Enterprise Value : 89.44M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 89.44M |
| September 04, 2026 | 95.02M |
| September 03, 2026 | 97.17M |
| September 02, 2026 | 98.03M |
| September 01, 2026 | 96.31M |
| August 31, 2026 | 102.33M |
| August 28, 2026 | 102.33M |
| August 27, 2026 | 104.04M |
| August 26, 2026 | 107.48M |
| August 25, 2026 | 107.48M |
| August 24, 2026 | 98.03M |
| August 21, 2026 | 97.17M |
| August 20, 2026 | 98.89M |
| August 19, 2026 | 99.32M |
| August 18, 2026 | 97.17M |
| August 17, 2026 | 95.88M |
| August 14, 2026 | 104.04M |
| August 13, 2026 | 92.88M |
| August 12, 2026 | 98.46M |
| August 11, 2026 | 97.17M |
| August 10, 2026 | 98.03M |
| August 07, 2026 | 87.72M |
| August 06, 2026 | 88.15M |
| August 05, 2026 | 85.15M |
| August 04, 2026 | 88.58M |
| Date | Value |
|---|---|
| August 03, 2026 | 91.16M |
| July 31, 2026 | 70.11M |
| July 30, 2026 | 69.26M |
| July 29, 2026 | 53.79M |
| July 28, 2026 | 53.79M |
| July 27, 2026 | 52.51M |
| July 24, 2026 | 50.36M |
| July 23, 2026 | 52.51M |
| July 22, 2026 | 52.08M |
| July 21, 2026 | 54.65M |
| July 20, 2026 | 58.30M |
| July 17, 2026 | 60.24M |
| July 16, 2026 | 62.38M |
| July 15, 2026 | 61.95M |
| July 14, 2026 | 63.67M |
| July 13, 2026 | 62.81M |
| July 10, 2026 | 66.25M |
| July 09, 2026 | 63.24M |
| July 08, 2026 | 62.38M |
| July 07, 2026 | 65.82M |
| July 06, 2026 | 63.67M |
| July 02, 2026 | 59.81M |
| July 01, 2026 | 63.24M |
| June 30, 2026 | 55.94M |
| June 29, 2026 | 50.64M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 210.25B |
| AngioDynamics, Inc. | 591.77M |
| Alphatec Holdings, Inc. | 1.912B |
| AtriCure, Inc. | 2.639B |
| Baxter International, Inc. | 19.53B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.08M |
| Revenue (Quarterly) | 22.76M |
| Total Expenses (Quarterly) | 32.84M |
| EPS Diluted (Quarterly) | -0.2374 |
| Gross Profit Margin (Quarterly) | 77.53% |
| Profit Margin (Quarterly) | -44.30% |
| Earnings Yield | -58.09% |
| Normalized Earnings Yield | -58.09 |